These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6303393)

  • 1. Noncooperative receptor interactions of glucagon and eleven analogues: inhibition of adenylate cyclase.
    England RD; Jenkins WT; Flanders KC; Gurd RS
    Biochemistry; 1983 Mar; 22(7):1722-8. PubMed ID: 6303393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor binding and adenylate cyclase activities of glucagon analogues modified in the N-terminal region.
    McKee RL; Pelton JT; Trivedi D; Johnson DG; Coy DH; Sueiras-Diaz J; Hruby VJ
    Biochemistry; 1986 Apr; 25(7):1650-6. PubMed ID: 3011069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural requirements for glucagon receptor binding and activation of adenylate cyclase in liver. Study of chemically modified forms of the hormone, including N alpha-trinitrophenyl glucagon, an antagonist.
    Epand RM; Rosselin G; Hoa DH; Cote TE; Laburthe M
    J Biol Chem; 1981 Feb; 256(3):1128-32. PubMed ID: 6256384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of nonspecific hydrophobic interactions in the biological activity of N epsilon-acyl derivatives of glucagon. Studies of conformation, receptor binding, and adenylate cyclase activation.
    Carrey EA; Epand RM
    J Biol Chem; 1982 Sep; 257(18):10624-30. PubMed ID: 6286664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic receptors, glucagon receptors, and their relationship to adenylate cyclase in rat liver during aging.
    Dax EM; Partilla JS; Piñeyro MA; Gregerman RI
    Endocrinology; 1987 Apr; 120(4):1534-41. PubMed ID: 3030705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon: structure-function relationships investigated by sequence deletions.
    Frandsen EK; Grønvald FC; Heding LG; Johansen NL; Lundt BF; Moody AJ; Markussen J; Vølund A
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):665-77. PubMed ID: 6268519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon receptor of human liver. Studies of its molecular weight and binding properties, and its ability to activate hepatic adenylyl cyclase of non-obese and obese subjects.
    Livingston JN; Einarsson K; Backman L; Ewerth S; Arner P
    J Clin Invest; 1985 Feb; 75(2):397-403. PubMed ID: 2982913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor occupancy and adenylate cyclase activation in rat liver and heart membranes by 10 glucagon analogs modified in position 2,3, 4, 25, 27 and/or 29.
    Robberect P; Damien C; Moroder L; Coy DH; Wünsch E; Christophe J
    Regul Pept; 1988 May; 21(1-2):117-28. PubMed ID: 2839870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats.
    Soman V; Felig P
    J Clin Invest; 1978 Mar; 61(3):552-60. PubMed ID: 205552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase.
    Hoosein NM; Gurd RS
    FEBS Lett; 1984 Dec; 178(1):83-6. PubMed ID: 6094259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of surface charge and hydrophobic interaction in the activation of rat liver adenylate cyclase.
    Rubalcava B; Grajales MO; Cerbon J; Pliego JA
    Biochim Biophys Acta; 1983 Sep; 759(3):243-9. PubMed ID: 6309252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon1-6 binds to the glucagon receptor and activates hepatic adenylate cyclase.
    Wright DE; Rodbell M
    J Biol Chem; 1979 Jan; 254(2):268-9. PubMed ID: 216670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of two glucagon antagonists: receptor binding, adenylate cyclase, and effects on blood plasma glucose levels.
    Gysin B; Johnson DG; Trivedi D; Hruby VJ
    J Med Chem; 1987 Aug; 30(8):1409-15. PubMed ID: 3039134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of specific trinitrophenylation of the lysine epsilon amino group of glucagon on receptor binding and adenylate cyclase activation.
    Liepnieks JJ; Epand RM
    Arch Biochem Biophys; 1983 Aug; 225(1):102-9. PubMed ID: 6311099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an essential serine residue in glucagon: implication for an active site triad.
    Unson CG; Merrifield RB
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):454-8. PubMed ID: 8290548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidylcholines can modulate the activity of the glucagon-stimulated adenylate cyclase from rat liver plasma membranes.
    Houslay MD; Palmer RW
    Biochem J; 1979 Jan; 178(1):217-21. PubMed ID: 435279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of glucagon receptors in rat brain.
    Hoosein NM; Gurd RS
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4368-72. PubMed ID: 6087321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of 2-thioltryptophan-glucagon and (tryptophan-S-glucagon)2. Differences in binding to the glucagon receptor in the hepatic adenylate cyclase system.
    Wright DE; Rodbell M
    J Biol Chem; 1980 Nov; 255(22):10884-7. PubMed ID: 7430160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatic glucagon receptor: a comparative study of the regulatory and structural properties.
    Padrell E; Herberg JT; Monsatirsky B; Floyd G; Premont RT; Iyengar R
    Endocrinology; 1987 Jun; 120(6):2316-25. PubMed ID: 3032585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colchicine improves the alterations in the liver adenylate cyclase system of cirrhotic rats.
    Mourelle M; Rojkind M; Rubalcava B
    Toxicology; 1981; 21(3):213-22. PubMed ID: 6170133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.